vs
RH（RH）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
RH的季度营收约是Royalty Pharma plc的1.4倍（$883.8M vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 4.1%，领先30.3%），RH同比增速更快（8.9% vs 4.8%），过去两年RH的营收复合增速更高（9.4% vs 4.6%）
RH是美国高端家居品牌，总部位于加利福尼亚州科尔特马德拉。品牌通过线下零售门店、产品目录和线上渠道发售家居商品，截至2018年8月，在美国和加拿大共运营70家展示馆、18家全系列设计展示馆、3家婴童家居展示馆，另有36家奥莱门店。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
RH vs RPRX — 直观对比
营收规模更大
RH
是对方的1.4倍
$622.0M
营收增速更快
RH
高出4.1%
4.8%
净利率更高
RPRX
高出30.3%
4.1%
两年增速更快
RH
近两年复合增速
4.6%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $883.8M | $622.0M |
| 净利润 | $36.3M | $214.2M |
| 毛利率 | 44.1% | — |
| 营业利润率 | 12.0% | 62.4% |
| 净利率 | 4.1% | 34.4% |
| 营收同比 | 8.9% | 4.8% |
| 净利润同比 | 9.3% | 2.9% |
| 每股收益（稀释后） | $1.83 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收RHRPRX
| Q4 25 | $883.8M | $622.0M | ||
| Q3 25 | $899.2M | $609.3M | ||
| Q2 25 | $814.0M | $578.7M | ||
| Q1 25 | $812.4M | $568.2M | ||
| Q4 24 | $811.7M | $593.6M | ||
| Q3 24 | $829.7M | $564.7M | ||
| Q2 24 | $727.0M | $537.3M | ||
| Q1 24 | $738.3M | $568.0M |
净利润RHRPRX
| Q4 25 | $36.3M | $214.2M | ||
| Q3 25 | $51.7M | $288.2M | ||
| Q2 25 | $8.0M | $30.2M | ||
| Q1 25 | $13.9M | $238.3M | ||
| Q4 24 | $33.2M | $208.2M | ||
| Q3 24 | $29.0M | $544.0M | ||
| Q2 24 | $-3.6M | $102.0M | ||
| Q1 24 | $11.4M | $4.8M |
毛利率RHRPRX
| Q4 25 | 44.1% | — | ||
| Q3 25 | 45.5% | — | ||
| Q2 25 | 43.7% | — | ||
| Q1 25 | 44.7% | — | ||
| Q4 24 | 44.5% | — | ||
| Q3 24 | 45.2% | — | ||
| Q2 24 | 43.5% | — | ||
| Q1 24 | 43.5% | — |
营业利润率RHRPRX
| Q4 25 | 12.0% | 62.4% | ||
| Q3 25 | 14.3% | 70.1% | ||
| Q2 25 | 6.9% | 36.3% | ||
| Q1 25 | 8.7% | 94.0% | ||
| Q4 24 | 12.5% | 60.9% | ||
| Q3 24 | 11.6% | — | ||
| Q2 24 | 7.5% | 50.2% | ||
| Q1 24 | 8.7% | -13.0% |
净利率RHRPRX
| Q4 25 | 4.1% | 34.4% | ||
| Q3 25 | 5.8% | 47.3% | ||
| Q2 25 | 1.0% | 5.2% | ||
| Q1 25 | 1.7% | 41.9% | ||
| Q4 24 | 4.1% | 35.1% | ||
| Q3 24 | 3.5% | 96.3% | ||
| Q2 24 | -0.5% | 19.0% | ||
| Q1 24 | 1.5% | 0.8% |
每股收益（稀释后）RHRPRX
| Q4 25 | $1.83 | $0.49 | ||
| Q3 25 | $2.62 | $0.67 | ||
| Q2 25 | $0.40 | $0.07 | ||
| Q1 25 | $0.71 | $0.55 | ||
| Q4 24 | $1.66 | $0.46 | ||
| Q3 24 | $1.45 | $1.21 | ||
| Q2 24 | $-0.20 | $0.23 | ||
| Q1 24 | $0.91 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $43.1M | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $3.3M | $9.7B |
| 总资产 | $4.8B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资RHRPRX
| Q4 25 | $43.1M | $618.7M | ||
| Q3 25 | $34.6M | $938.9M | ||
| Q2 25 | $46.1M | $631.9M | ||
| Q1 25 | $30.4M | $1.1B | ||
| Q4 24 | $87.0M | $929.0M | ||
| Q3 24 | $78.3M | $950.1M | ||
| Q2 24 | $101.8M | $1.8B | ||
| Q1 24 | $123.7M | $843.0M |
总债务RHRPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益RHRPRX
| Q4 25 | $3.3M | $9.7B | ||
| Q3 25 | $-40.9M | $9.6B | ||
| Q2 25 | $-110.8M | $9.5B | ||
| Q1 25 | $-163.6M | $9.8B | ||
| Q4 24 | $-183.0M | $10.3B | ||
| Q3 24 | $-234.7M | $10.3B | ||
| Q2 24 | $-289.9M | $9.8B | ||
| Q1 24 | $-297.4M | $9.9B |
总资产RHRPRX
| Q4 25 | $4.8B | $19.6B | ||
| Q3 25 | $4.7B | $19.3B | ||
| Q2 25 | $4.7B | $18.3B | ||
| Q1 25 | $4.6B | $17.6B | ||
| Q4 24 | $4.5B | $18.2B | ||
| Q3 24 | $4.4B | $18.0B | ||
| Q2 24 | $4.2B | $17.7B | ||
| Q1 24 | $4.1B | $16.1B |
负债/权益比RHRPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $131.9M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $83.0M | — |
| 自由现金流率自由现金流/营收 | 9.4% | — |
| 资本支出强度资本支出/营收 | 5.5% | — |
| 现金转化率经营现金流/净利润 | 3.64× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $128.1M | — |
8季度趋势，按日历期对齐
经营现金流RHRPRX
| Q4 25 | $131.9M | $827.1M | ||
| Q3 25 | $137.7M | $702.6M | ||
| Q2 25 | $86.6M | $364.0M | ||
| Q1 25 | $-18.8M | $596.1M | ||
| Q4 24 | $-31.4M | $742.5M | ||
| Q3 24 | $11.2M | $703.6M | ||
| Q2 24 | $56.1M | $658.2M | ||
| Q1 24 | $-114.0M | $664.6M |
自由现金流RHRPRX
| Q4 25 | $83.0M | — | ||
| Q3 25 | $80.7M | — | ||
| Q2 25 | $34.1M | — | ||
| Q1 25 | $-69.7M | — | ||
| Q4 24 | $-96.0M | — | ||
| Q3 24 | $-37.9M | — | ||
| Q2 24 | $-10.1M | — | ||
| Q1 24 | $-251.5M | — |
自由现金流率RHRPRX
| Q4 25 | 9.4% | — | ||
| Q3 25 | 9.0% | — | ||
| Q2 25 | 4.2% | — | ||
| Q1 25 | -8.6% | — | ||
| Q4 24 | -11.8% | — | ||
| Q3 24 | -4.6% | — | ||
| Q2 24 | -1.4% | — | ||
| Q1 24 | -34.1% | — |
资本支出强度RHRPRX
| Q4 25 | 5.5% | — | ||
| Q3 25 | 6.3% | — | ||
| Q2 25 | 6.5% | — | ||
| Q1 25 | 6.3% | — | ||
| Q4 24 | 8.0% | — | ||
| Q3 24 | 5.9% | — | ||
| Q2 24 | 9.1% | — | ||
| Q1 24 | 18.6% | — |
现金转化率RHRPRX
| Q4 25 | 3.64× | 3.86× | ||
| Q3 25 | 2.66× | 2.44× | ||
| Q2 25 | 10.78× | 12.06× | ||
| Q1 25 | -1.35× | 2.50× | ||
| Q4 24 | -0.95× | 3.57× | ||
| Q3 24 | 0.39× | 1.29× | ||
| Q2 24 | — | 6.45× | ||
| Q1 24 | -10.01× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
RH
| RH Segment | $835.8M | 95% |
| Waterworks Segment | $48.0M | 5% |
| Gift Card And Merchandise Credit | $4.5M | 1% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
